Company Number: SC725930

Analysis Date: 2025-07-29 16:37 UTC

Financial Health Assessment for Assure Asbestos Ltd

---

1. Financial Health Score: D (Below Average Health)

Explanation:
Assure Asbestos Ltd shows clear signs of financial distress, with persistent net liabilities and negative working capital over the last two years. Although the company has some tangible fixed assets, the current liabilities significantly exceed current assets, indicating liquidity challenges. The financial "vital signs" suggest the business is struggling to maintain a healthy cash flow and sufficient resources to meet short-term obligations.

---

2. Key Vital Signs

Metric	2024 Value (£)	Interpretation
Net Current Assets (Working Capital)	-5,648	Negative working capital signals potential cash flow problems and difficulty meeting short-term debts.
Net Assets (Shareholders’ Funds)	-9,372	Negative equity indicates liabilities exceed assets, a symptom of financial distress.
Cash at Bank	6,957	Cash balance is modest but insufficient to cover current liabilities (14,841).
Current Liabilities	14,841	High current obligations relative to assets risk liquidity crises.
Fixed Assets (Plant & Machinery)	22,724	Reasonable investment in fixed assets, but may not be easily liquidated to cover debts.
Debt Structure	-26,448 (Long and short term combined)	Heavy reliance on bank loans and hire purchase contracts increases financial risk.

---

3. Diagnosis: Underlying Business Health

• Liquidity "Symptoms": The company consistently exhibits negative working capital, indicating cash flow is "unhealthy." The cash on hand is less than half the current liabilities, suggesting a risk of insolvency if creditors demand payment or if cash inflows are delayed.

• Capital Structure: Negative net assets (shareholders' funds) imply that the company's debts exceed its total assets, akin to a "deficiency in vital reserves." This reflects accumulated losses or undercapitalization since inception in 2022.

• Debt Burden: The significant bank loans and hire purchase obligations (both short and long-term) are placing a heavy strain on finances. The increase in hire purchase debt from £6,740 (2023 total) to £22,114 (2024 total) indicates increased leverage, which raises concerns about debt servicing capacity.

• Asset Base: The company has increased its investment in tangible fixed assets substantially, which may be a positive sign of growth or expansion. However, these assets are not very liquid and cannot be quickly converted to cash in a crisis.

• Absence of Income Statement: The lack of published profit and loss data limits a full assessment of profitability and operational cash flows, but the balance sheet signals losses or negative retained earnings.

• Operational Scale: No employees are recorded, which suggests the company may be reliant on contractors or directors themselves, potentially controlling costs but also limiting growth capacity.

• Directors and Control: The company is controlled by three directors owning equal shares, indicating a concentrated ownership structure that can be agile but may face challenges raising external capital.

---

4. Recommendations: Path to Financial Wellness

• Improve Liquidity: Prioritize strengthening cash flow management through tighter credit control on debtors, negotiating extended payment terms with suppliers, or securing short-term financing to avoid liquidity shortfalls.

• Debt Restructuring: Engage lenders to restructure existing bank loans and hire purchase agreements, possibly extending repayment terms or refinancing to reduce immediate cash flow burdens.

• Cost Control and Profitability: Since the company has no recorded employees, ensure overheads and operating expenses are controlled. A detailed review of pricing, contract profitability, and cost drivers is essential to achieve a sustainable profit margin.

• Asset Utilization: Evaluate the fixed assets to ensure they contribute effectively to revenue generation. Consider asset disposals if they do not support core operational needs and can provide cash relief.

• Capital Injection: Given negative equity, consider new capital injection from existing shareholders or external investors to restore the company's financial "vital reserves" and improve solvency.

• Transparency and Reporting: Publish full income statements and cash flow statements in future filings to provide stakeholders with a clearer picture of operational health and assist in timely decision-making.

• Professional Advice: Given the symptoms of financial distress, proactive consultation with insolvency practitioners or financial advisors may help design a turnaround plan before conditions worsen.

---

Medical Analogy Summary

Assure Asbestos Ltd's financial health is akin to a patient with "poor circulation"—the cash flow (blood flow) is insufficient to meet the body's immediate needs, causing the company to run a "deficit" in working capital (oxygen supply). The "organs" (assets) are intact but not easily accessible for emergency needs. Without intervention to improve "circulation" and reduce "debt load," the company risks further deterioration that could lead to "organ failure" (insolvency).

---